Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Metab Dispos ; 24(7): 792-8, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8818578

ABSTRACT

The uptake of estrone sulfate (E1S; 1 to 400 microM), harmol sulfate (HS; 5 to 900 microM), and 4-methylumbelliferyl sulfate (4MUS; 5 to 1000 microM) was investigated in isolated rat hepatocytes in the presence or absence of inhibitors. Uptake of all of the sulfate conjugates was rapid and exhibited saturation kinetics, best characterized by saturable and nonsaturable (linear transmembrane clearance) transport systems. The KM's were: 16 +/- 6, 123 +/- 28, and 64 +/- 6 microM for E1S, HS, and 4MUS, respectively, with corresponding Vmax's of 0.85 +/- 0.56, 0.48 +/- 14, and 0.42 +/- 0.07 nmol/min/10(6) cells. The nonsaturable uptake clearances, which displayed concentration-independent uptake, were 3 +/- 2, 1 +/- 0.1, 0.5 +/- 0.1 microliter/min/10(6) cells, respectively. Uptake of E1S was inhibited by ouabain (1 mM) and replacement of sodium by choline, whereas HS was insensitive to the addition or substitution. Uptake of both E1S and HS was significantly reduced by metabolic inhibitors (antimycin A, 2.7 microM, rotenone, 30 microM, and KCN, 2 mM) and temperature reduction (from 37 to 27 degrees C). 4,4'-Diisothiocyanostilbene-2-2-'disulfonic acid (2 mM), an inhibitor of anion transport, reduced E1S and HS uptake; E1S uptake was also reduced by HS. HS uptake by both saturable and nonsaturable transport components was depressed by 4MUS (300 microM); the apparent KM was increased by 83% while the Vmax remained unaltered, and the nonsaturable component was decreased by 48%. The data strongly suggest that multiple pathways exist for the uptake of E1S, HS, and 4MUS. E1S uptake is sodium-dependent, requires energy, and is inhibited by anions such as 4,4'diisothiocyanostilbene-2-2'-disulfonic acid and other sulfate conjugates. HS uptake, while being energy dependent, is not sodium dependent, and is inhibited by 4MUS in a competitive fashion. At least one of these pathways is shared.


Subject(s)
Estrogens, Conjugated (USP)/pharmacokinetics , Estrone/analogs & derivatives , Harmine/analogs & derivatives , Hymecromone/analogs & derivatives , Liver/metabolism , 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology , Animals , Biological Transport/drug effects , Carrier Proteins/metabolism , Choline/pharmacology , Estrone/pharmacokinetics , Harmine/pharmacokinetics , Hymecromone/pharmacokinetics , In Vitro Techniques , Liver/cytology , Male , Ouabain/pharmacology , Rats , Rats, Sprague-Dawley
2.
Toxicol Lett ; 51(2): 203-11, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2139521

ABSTRACT

Experiments were conducted to determine the UDP-glucuronyltransferase (UDP-GT) isoenzyme which catalyzes zearalenone (Z) conjugation, and the effect of increased enzyme activity on Z metabolism. In competitive enzyme assays, the activity of rat liver UDP-GT towards Z was inhibited by 1-naphthol (NA), a GT1 substrate, and 4-hydroxybiphenyl (HB), a GT2 substrate. When enzyme activity was induced with either 3-methylcholanthrene (MC), a GT1 inducer, or phenobarbital (PB), a GT2 inducer, increased UDP-GT activity towards Z, NA and HB was observed. UDP-GT induction by PB increased urinary excretion of conjugated alpha-zearalenol. These results indicate that UDP-GT isoenzymes have overlapping substrate specificities, and that Z detoxification may be enhanced by UDP-GT enzyme induction, resulting in increased urinary excretion of conjugated alpha-zearalenol.


Subject(s)
Glucuronosyltransferase/metabolism , Isoenzymes/metabolism , Resorcinols/metabolism , Zearalenone/metabolism , Animals , Biphenyl Compounds/pharmacology , Enzyme Induction/drug effects , Female , Glucuronosyltransferase/antagonists & inhibitors , Inactivation, Metabolic/physiology , Liver/drug effects , Liver/enzymology , Methylcholanthrene/pharmacology , Naphthols/pharmacology , Phenobarbital/pharmacology , Rats , Rats, Inbred Strains , Zearalenone/pharmacology
3.
J Environ Sci Health B ; 23(4): 343-54, 1988 Aug.
Article in English | MEDLINE | ID: mdl-2973490

ABSTRACT

Young female rats were orally dosed with either 1 or 100 mg zearalenone kg-1 body weight; zearalenone and metabolites were measured in a 96-h collection of urine and feces by HPLC analysis. Dose had little effect on metabolites formed, or excretion route. In both treatment groups, about 55% of the oral dose was excreted in the feces, while the urine was also a major route of excretion accounting for 15-20% of the administered dose. Zearalenone and metabolites were excreted mainly in the free form, with the production of alpha-zearalenol, the most potent estrogenic metabolite, being greater than 10% of the zearalenone dose.


Subject(s)
Resorcinols/metabolism , Zearalenone/metabolism , Animals , Dose-Response Relationship, Drug , Feces/analysis , Female , Rats , Rats, Inbred Strains , Zearalenone/urine , Zeranol/analogs & derivatives , Zeranol/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...